Brought to you by 
Speedel files for, then withdraws IPO; lists shares on SWX
May 2005
Executive Summary
Speedel (cardiovascular and renal therapeutics) filed for its initial public offering last month but has since withdrawn it, citing poor market conditions. It had planned to trade on the Swiss Exchange after raising up to several hundred million Swiss francs.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Speedel files for, then withdraws IPO; lists shares on SWX
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice